Not applicableUnknownNCT06483152What this trial is testingUnlimited Transportation Passes for Unstable Housed People Living With HIV TrialWho this might be right forHIV The Aliveness Project 146
Not applicableLooking for participantsNCT06576648What this trial is testingThailand HIV and Stigma Reduction StudyWho this might be right forPre-Exposure Prophylaxis University of Massachusetts, Worcester 154
Not applicableStudy completedNCT02481492What this trial is testingRandomized Controlled Trial of Shang Ring Male Children Circumcision: Comparison Between Flip and No Flip TechniqueWho this might be right forHuman Immunodeficiency Virus Ningbo No. 1 Hospital 100
Large-scale testing (Phase 3)Study completedNCT00197704What this trial is testingNutrition, Immunology and Epidemiology of TuberculosisWho this might be right forTuberculosis Harvard School of Public Health (HSPH) 876
Post-approval studies (Phase 4)Study completedNCT00240552What this trial is testingFosamprenavir Expanded AccessWho this might be right forInfection, Human Immunodeficiency Virus ViiV Healthcare 85
Not applicableStudy completedNCT02693847What this trial is testingNatural History of Liver Cirrhosis Diagnosed by Transient Elastography in HIV/HCV-coinfected PatientsWho this might be right forLiver CirrhosisHepatocellular CarcinomaHIV+1 more Hospital Universitario de Valme 446
Not applicableStudy completedNCT04545164What this trial is testingComputer Aided Screening for Tuberculosis in Low Resource EnvironmentsWho this might be right forTuberculosis InfectionHIV Infections London School of Hygiene and Tropical Medicine 498
Testing effectiveness (Phase 2)UnknownNCT00622232What this trial is testingA Rollover Study for Subjects Who Completed Participation in the VRX496-USA-05-002 TrialWho this might be right forHIV Infections VIRxSYS Corporation 40
Post-approval studies (Phase 4)Ended earlyNCT00414284What this trial is testingBOOST: Study of Increased Dosage of Lopinavir/Ritonavir (LPV/r)Who this might be right forHIV Infections Community Research Initiative of New England
Not applicableStudy completedNCT01009749What this trial is testingMotivational Enhancement System for AdherenceWho this might be right forHIV University of North Carolina, Chapel Hill 76
Not applicableStudy completedNCT05377138What this trial is testingEvaluate and Optimize an Online Care Model for PrEP Delivery: Pilot StudyWho this might be right forHIV Infections University of Washington 2,357
Testing effectiveness (Phase 2)Study completedNCT00033163What this trial is testingA Comparison of Adefovir and Tenofovir for the Treatment of Lamivudine-Resistant Hepatitis B Virus in People With HIVWho this might be right forHIV InfectionsHepatitis B National Institute of Allergy and Infectious Diseases (NIAID) 90
Not applicableStudy completedNCT05223114What this trial is testingAirway Microbiome and Th17-mediated Inflammation in COPD Among HIV-infected Individuals in a Rural Ugandan CohortWho this might be right forCOPDHIV InfectionsRespiratory Disease Makerere University 160
Early research (Phase 1)Study completedNCT02430506What this trial is testingEvaluate Safety and Immunogenicity of AERAS-402 Administered in HIV-negative, BCG-vaccinated, QFT (+) and (-) Adults Without Evidence of TBWho this might be right forTuberculosis Aeras 20
Not applicableStudy completedNCT04155684What this trial is testingDysbiosis Impact on Lung Disease in HIVWho this might be right forHIV InfectionsCOPDMicrobiome University of Pittsburgh 50
Not applicableStudy completedNCT05855655What this trial is testingDeveloping an Online Mindfulness-based Intervention to Reduce Minority Stress and HIV Risk Among Young Adult MSM - Aim 3Who this might be right forHivMinority StressMental Health Wellness 1 Brown University 68
Not applicableStudy completedNCT03835832What this trial is testingSelf-Assessment Tuberculin Skin TestWho this might be right forTuberculin Skin Test The HIV Netherlands Australia Thailand Research Collaboration 215
Early research (Phase 1)Study completedNCT00001021What this trial is testingA Phase I Multicenter Study of the Safety and Immunogenicity of MN rgp120/HIV-1 Vaccine Given Either Alone or in Combination With IIIB rgp120/HIV-1 Vaccine in Healthy Adult Subjects (NOTE: Original Study Extended ONLY for Patients Previously Enrolled on VEU 009)Who this might be right forHIV Infections National Institute of Allergy and Infectious Diseases (NIAID) 57
Large-scale testing (Phase 3)Study completedNCT01900106What this trial is testingA Prospective, Open-label Trial of Two ABC/3TC Based Regimens in Late Presenter naïve Patients (CD4 <200 Cells/µL)Who this might be right forHIV Infection University of Modena and Reggio Emilia 47
Large-scale testing (Phase 3)Not Yet RecruitingNCT06276504What this trial is testingPembrolizumab in Progressive Multifocal Leukoencephalopathy (PML) in Immunocompromised Patients Without HIV InfectionWho this might be right forProgressive Multifocal Leukoencephalopathy Assistance Publique - Hôpitaux de Paris 33